Altus signs up with Zogenix for pain drug formulation; Catalent launches drug delivery search engine;

> Contract developer Altus Formulation has signed up with Zogenix ($ZGNX) to concoct abuse-deterrent formulations of its recently approved Zohydro ER pain drug. News

> ImmunoGen ($IMGN) has inked another Big Pharma development partnership, this time pairing up with Novartis ($NVS) to make use of its antibody-drug conjugate technology. More

> Catalent has launched a web-based tool to help clients decide which drug delivery method is best for specific compounds. Article

Suggested Articles

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.

After three full business days in the position, an abrupt about-face has LabCorp Diagnostics’ CEO John Ratliff heading for the exit.

The initiative will see Evotec mine a kidney biobank for new renal therapy targets before the joint venture out-licenses resulting assets to Vifor.